Related Experiment Videos
Transjugular liver biopsy effecting changes in clinical management.
David Lee1, Shivakumar Chitturi, James Kench
1Department of Radiology, Westmead Hospital and Westmead Millennium Institute, University of Sydney, Sydney, Australia.
Australasian Radiology
|June 5, 2003
Summary
Transjugular liver biopsies are safe and effective for patients with impaired blood coagulation. This procedure aids accurate liver diagnosis and influences clinical management decisions in high-risk individuals.
Area of Science:
- Hepatology
- Interventional Radiology
- Gastroenterology
Background:
- Transjugular liver biopsy is often used in patients with coagulation issues.
- The impact of these biopsies on clinical management is not well-established.
Purpose of the Study:
- To assess the technical success, complication rates, and clinical management changes following transjugular liver biopsies in patients with impaired blood coagulation.
Main Methods:
- Retrospective review of 43 transjugular liver biopsies performed between 1998-2000.
- Data collected included technical success, complications, and changes in patient management.
- Cook 20-G transjugular cutting needle device was used for all procedures.
Main Results:
- Adequate histological samples were obtained in 98% of biopsies.
- Clinical diagnosis was changed in 28% of patients, leading to management alterations in all cases.
- Four patients experienced procedural complications, with one major complication requiring surgery.
Conclusions:
- Transjugular liver biopsy is a safe and effective procedure for high-risk patients with impaired coagulation.
- The procedure provides accurate histological assessment and influences clinical decision-making.
- It is a valuable tool for evaluating liver dysfunction in specific patient populations.